Skip to main content
. 2017 Nov 16;7(11):e014549. doi: 10.1136/bmjopen-2016-014549

Table 5.

CD19 lymphocyte ratios in vitreous samples

n Mean SD Difference in average value Effect size: d p Value
D-sarcoidosis 61 0.42 0.82 0.16 0.26 >0.9999
S-sarcoidosis 60 0.27 0.37
D-sarcoidosis 61 0.42 0.82 0.28 0.31 >0.9999
Non-sarcoidosis 16 0.70 0.95
D-sarcoidosis 61 0.42 0.82 1.42 0.63 0.1123
Viral infection 20 1.84 3.69
D-sarcoidosis 61 0.42 0.82 29.06 1.89 <0.0001
Tumour 34 29.48 29.92
D-sarcoidosis 61 0.42 0.82 0.54 0.46 0.6018
Unknown 43 0.96 1.53
S-sarcoidosis 60 0.27 0.37 0.43 0.65 >0.9999
Non-sarcoidosis 16 0.70 0.95
S-sarcoidosis 60 0.27 0.37 1.57 0.77 0.0717
Viral infection 20 1.84 3.69
S-sarcoidosis 60 0.27 0.37 29.21 1.93 <0.0001
Tumour 34 29.48 29.92
S-sarcoidosis 60 0.27 0.37 0.69 0.73 0.3762
Unknown 43 0.96 1.53
Non-sarcoidosis 16 0.70 0.95 1.14 0.49 >0.9999
Viral infection 20 1.84 3.69
Non-sarcoidosis 16 0.70 0.95 28.78 1.86 0.0017
Tumour 34 29.48 29.92
Non-sarcoidosis 16 0.70 0.95 0.26 0.21 >0.9999
Unknown 43 0.96 1.53
Viral infection 20 1.84 3.69 27.64 1.64 0.0113
Tumour 34 29.48 29.92
Viral infection 20 1.84 3.69 0.88 0.34 >0.9999
Unknown 43 0.96 1.53
Tumour 34 29.48 29.92 28.52 1.81 <0.0001
Unknown 43 0.96 1.53